Gynecological Devices Market Size, Share & Trends Analysis - Europe - 2024-2030 - MedSuite - Includes: Assisted Reproduction Technology, Endometrial Ablation Devices, Gynecological Resection Electrodes, and 6 more
Product Description
In 2023, the European gynecological device market was valued at approximately €383 million. This market is projected to grow at a compound annual growth rate (CAGR) of 2.4%, reaching over €450 million during the forecast period. The comprehensive report on the European market for gynecological devices includes segments such as assisted reproduction technology, global endometrial ablation devices, gynecological resection electrodes, morcellators, uterine fibroid embolization devices, gynecological endoscopes, fluid management equipment, pelvic organ prolapse repair devices, and hysterosalpingography (HSG) catheters. Additionally, the report features appendix sections on laser technology and pelvic floor electrical stimulation devices.
Data Types IncludedUnit Sales, Average Selling Prices, Market Value & Growth Trends
Gynecological Procedure Volumes
Market Forecasts Until 2030, and Historical Data to 2020
Competitive Analysis with Market Shares for Each Segment
Market Drivers & Limiters for Each Gynecology Device market
Recent Mergers & Acquisitions
Disease Overviews and Demographic Information
Company Profiles, Product Portfolios, and SWOT for Top Competitors
European Gynecology Devices Market InsightsA significant trend in the European market for gynecological devices is the growing preference for minimally invasive treatments to avoid hysterectomies when possible. Conditions such as fibroids and endometriosis, which affect many women in Europe, are traditionally treated with birth control, surgery, or in severe cases, hysterectomy. However, due to the invasive nature and lengthy recovery associated with hysterectomy, physicians are increasingly favoring less invasive options like hysteroscopic surgeries, uterine artery embolization, and endometrial ablation. These alternatives offer quicker recovery times and are becoming more popular among patients.
Gynecology Devices Market Share InsightsIn 2023, Cooper Surgical led the gynecology market, supported by its robust portfolio in assisted reproduction technology, colposcopes, and hysterosalpingography. The acquisition of Cook Medical’s assisted reproduction technology significantly enhanced Cooper Surgical’s market share in this segment.
Karl Storz secured the second-largest market share in 2023, driven by its diverse offerings in hysteroscopes, morcellators, and fluid management equipment. This specialization helped Karl Storz maintain a strong market position.
Vitrolife captured a significant share of the European assisted reproduction technology market in 2023, being active in four out of five segments. Known for its innovation, Vitrolife is expected to sustain strong market value throughout the forecast period.
Market Segmentation SummaryAssisted Reproduction Device Market – MedCore – Includes:
Device Type: Oocyte Retrieval Needle, Micropipette, Embryo Transfer Catheter, Reproduction Media, Embryo Time-Lapse Incubator.
Endometrial Ablation Device Market – MedCore – Includes:
Device Type: Thermal Ablation Device, Radiofrequency Ablation Device.
Endometrial Resection Electrode Device Market – MedCore – Includes:
Device Type: Monopolar Loop Electrode, Bipolar Loop Electrode, and Electrosurgical Rollerball.
Morcellator Market – MedCore – Includes:
Device Type: Laparoscopic, Hysteroscopic.
Uterine Fibroid Embolization Market – MedCore – Includes:
Device Type: Microsphere, PVA Particle.
Gynecological Endoscope Device Market – MedCore – Includes:
Device Type: Hysteroscope, Colposcope, Resectoscope.
Fluid Management Equipment Market – MedCore – Includes:
Device Type: Fluid Management Capital Equipment, Fluid Management Tubing.
Pelvic Organ Prolapse Repair Device Market – MedCore – Includes:
Device Type: Transvaginal Mesh, Sacrocolpopexy Mesh.
Hysterosalpingography (HSG) Catheter – MedCore
Pelvic Floor Electrical Stimulation Device– MedCore*
Laser Technology – MedCore*"